Boston-based Allied Minds, a pre-seed investment corporation specializing in early stage university business ventures, has partnered with Wayne State University to establish GliaGen LLC, a start-up company which will develop new diagnostic and therapeutic technologies to treat neurodegenerative diseases. The newly formed company has exclusively secured platform technology developed by Leon Carlock and Maria Cypher, of the Center for Molecular Medicine and Genetics at Wayne State's School of Medicine. The technologies provide new tools for understanding neural disease processes, as well as cellular repair mechanisms.